C.M. Bidwell & Associates’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

C.M. Bidwell & Associates’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,565	Closed	-$263K	–	636
2021 Q2	$263K	Buy	+9,565	New	+$188K	0.17%	108

C.M. Bidwell & Associates's TBIO Position: Q3 2021 in Review

C.M. Bidwell & Associates sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 9,565 shares — an estimated $263K sold.

C.M. Bidwell & Associates first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $263K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

C.M. Bidwell & Associates reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
C.M. Bidwell & Associates sold 9,565 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $263K.
C.M. Bidwell & Associates first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
C.M. Bidwell & Associates's Translate Bio, Inc. Common Stock position peaked at $263K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2021, filed 12 Nov 2021.